Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity

Carcinogenesis. 1996 Nov;17(11):2305-9. doi: 10.1093/carcin/17.11.2305.

Abstract

Nuclear factor kappaB (NF-kappaB) is an important stress-induced transcription factor in many cell types, including hepatocytes. Previous studies have shown that reactive oxygen species, including hydrogen peroxide, are potent activators of NF-kappaB. Peroxisome proliferators are a group of rodent chemical carcinogens that have been proposed to act by increasing reactive oxygen in the liver. These results led us to consider whether peroxisome proliferators would increase NF-kappaB activity in the liver. Here we demonstrate that rats fed diets containing the peroxisome proliferator ciprofibrate exhibit increased hepatic NF-kappaB DNA-binding activity. This observation suggests that NF-kappaB may contribute, in part, to peroxisome proliferator-mediated changes in the liver.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Binding Sites
  • Clofibric Acid / analogs & derivatives*
  • Clofibric Acid / pharmacology
  • DNA / metabolism
  • Electrophoresis
  • Fibric Acids
  • Hypolipidemic Agents / pharmacology*
  • Liver / drug effects*
  • Liver / metabolism*
  • Microbodies / drug effects*
  • Microbodies / metabolism*
  • NF-kappa B / metabolism*
  • Rats

Substances

  • Fibric Acids
  • Hypolipidemic Agents
  • NF-kappa B
  • Clofibric Acid
  • DNA
  • ciprofibrate